Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has provided an announcement.
Wai Chun Bio-Technology Ltd. has announced an extraordinary general meeting to discuss a significant capital restructuring plan. The company aims to reduce the par value of its issued ordinary shares from HK$0.25 to HK$0.01 and adjust its share capital structure. This move is expected to offset accumulated losses and potentially improve financial flexibility, impacting the company’s market positioning and shareholder value.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology sector. The company is listed on the Stock Exchange of Hong Kong and focuses on developing and providing biotechnology products and services.
YTD Price Performance: 50.0%
Average Trading Volume: 178,869
Technical Sentiment Signal: Buy
Current Market Cap: HK$18.01M
For a thorough assessment of 0660 stock, go to TipRanks’ Stock Analysis page.